share_log

康弘药业:关于调整公司2023年股票增值权激励计划行权价格的公告

Chengdu Kanghong Pharmaceutical Group: Announcement on adjusting the exercise price of the Company's 2023 Stock Value-added Rights Incentive Plan

SZSI ·  May 28
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more